Rate My Professor Anne Vertigan

Vertigan's research specializations focus on voice disorders, chronic cough and vocal cord dysfunction (VCD), laryngectomy, and dysphagia, with particular emphasis on speech pathology management of chronic refractory cough, laryngeal hypersensitivity, and inducible laryngeal obstruction. She conducted the first randomised controlled trial on the efficacy of speech pathology for chronic cough, published in Thorax in 2006. Key contributions include co-authoring influential CHEST guidelines such as 'Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report' (Chest, 2016), 'Classification of Cough as a Symptom in Adults and Management Algorithms: CHEST Guideline and Expert Panel Report' (Chest, 2018), and 'Chronic Cough Due to Gastroesophageal Reflux in Adults: CHEST Guideline and Expert Panel Report' (Chest, 2016). She authored the book 'Speech Pathology Management of Chronic Refractory Cough and Related Disorders' (2016) and led the development of the Newcastle Laryngeal Hypersensitivity Questionnaire, which is used internationally and translated into multiple languages. Other notable publications encompass 'Pregabalin and Speech Pathology Combination Therapy for Refractory Chronic Cough: A Randomized Controlled Trial' (Chest, 2016) and over 120 journal articles, 10 book chapters, and numerous conference presentations. Her work, cited more than 4,000 times on ResearchGate, has significantly impacted the management of cough hypersensitivity syndromes and respiratory-related laryngeal disorders through participation in international expert panels.